FPHAX vs. FSMEX
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FPHAX or FSMEX.
Performance
FPHAX vs. FSMEX - Performance Comparison
Returns By Period
In the year-to-date period, FPHAX achieves a 13.18% return, which is significantly higher than FSMEX's 9.80% return. Over the past 10 years, FPHAX has underperformed FSMEX with an annualized return of 3.18%, while FSMEX has yielded a comparatively higher 6.21% annualized return.
FPHAX
13.18%
-8.54%
-6.85%
17.79%
4.43%
3.18%
FSMEX
9.80%
1.75%
5.92%
20.24%
3.11%
6.21%
Key characteristics
| FPHAX | FSMEX | |
|---|---|---|
| Sharpe Ratio | 1.11 | 1.31 |
| Sortino Ratio | 1.61 | 1.89 |
| Omega Ratio | 1.20 | 1.23 |
| Calmar Ratio | 0.96 | 0.54 |
| Martin Ratio | 3.68 | 4.75 |
| Ulcer Index | 4.84% | 4.26% |
| Daily Std Dev | 16.02% | 15.40% |
| Max Drawdown | -37.34% | -43.45% |
| Current Drawdown | -15.55% | -23.85% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. FSMEX - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is higher than FSMEX's 0.68% expense ratio.
Correlation
The correlation between FPHAX and FSMEX is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
FPHAX vs. FSMEX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FPHAX vs. FSMEX - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 0.75%, while FSMEX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.75% | 0.63% | 1.33% | 1.17% | 1.31% | 1.31% | 1.44% | 1.33% | 1.07% | 5.59% | 5.81% | 11.12% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% | 9.84% |
Drawdowns
FPHAX vs. FSMEX - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -37.34%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FPHAX and FSMEX. For additional features, visit the drawdowns tool.
Volatility
FPHAX vs. FSMEX - Volatility Comparison
Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 6.50% compared to Fidelity Select Medical Technology and Devices Portfolio (FSMEX) at 3.70%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.